Dingdang Health Technology Group Ltd. (HKG:9886)

HKG:9886 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	429.32	1,218	1,186	1,211	1,553
Short-Term Investments	415.28	-	-	-	-
Trading Asset Securities	244.54	-	143.43	136.8	-
Cash & Short-Term Investments	1,089	1,218	1,329	1,348	1,553
Cash Growth	-10.58%	-8.38%	-1.37%	-13.22%	166.81%
Accounts Receivable	225	239.06	114.26	239.55	145.86
Other Receivables	50.53	48.08	162.85	37.39	42.36
Receivables	275.53	287.14	277.11	276.94	188.23
Inventory	647.73	571.25	612.33	607.95	434.02
Prepaid Expenses	47.36	39.04	28.4	43.96	34.28
Other Current Assets	76.23	86.24	124.85	250.99	58.17
Total Current Assets	2,136	2,202	2,372	2,528	2,268
Property, Plant & Equipment	339	205.9	193.93	217.36	213.53
Long-Term Investments	223.92	59.99	95.09	116.16	-
Goodwill	56.85	56.85	255.76	255.76	255.76
Other Intangible Assets	61.51	92.84	133.62	169.98	199.24
Other Long-Term Assets	16.91	15.5	14.35	10.63	9.93
Total Assets	2,834	2,633	3,065	3,297	2,946

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	540.63	434.98	498.94	430.38	340.52
Accrued Expenses	237.04	238.75	254.39	288.71	214.43
Short-Term Debt	4.65	-	-	-	0.23
Current Portion of Leases	71.79	54.93	56.08	72.13	61.38
Current Income Taxes Payable	11.56	5.82	4.11	4.95	8.6
Current Unearned Revenue	28.72	45.1	32.37	90.18	59.78
Other Current Liabilities	42.77	52.45	66.66	82.98	53.98
Total Current Liabilities	937.15	832.02	912.54	969.33	738.93
Long-Term Debt	-	-	-	-	4,651
Long-Term Leases	205.37	97.68	84.13	91.01	95.63
Long-Term Unearned Revenue	3.99	3.49	2.98	3.84	8.9
Long-Term Deferred Tax Liabilities	12.75	19.26	28.22	34.1	41.58
Total Liabilities	1,159	952.45	1,028	1,098	5,536

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.88	0.88	0.89	0.89	0.4
Additional Paid-In Capital	7,467	7,467	7,479	7,479	-
Retained Earnings	-6,505	-6,456	-6,079	-5,853	-3,020
Treasury Stock	-51.24	-39.07	-18.84	-	-
Comprehensive Income & Other	750.98	686.57	655.13	558.71	407.28
Total Common Equity	1,663	1,660	2,037	2,186	-2,612
Minority Interest	11.47	20.02	-0.53	13.54	22.42
Shareholders' Equity	1,675	1,680	2,037	2,199	-2,590
Total Liabilities & Equity	2,834	2,633	3,065	3,297	2,946

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	281.81	152.61	140.21	163.14	4,808
Net Cash (Debt)	807.33	1,065	1,189	1,185	-3,255
Net Cash Growth	-24.22%	-10.41%	0.38%	-	-
Net Cash Per Share	0.62	0.81	0.89	1.41	-6.82
Filing Date Shares Outstanding	1,310	1,319	1,341	1,341	630.79
Total Common Shares Outstanding	1,310	1,319	1,341	1,341	630.79
Working Capital	1,199	1,370	1,459	1,558	1,529
Book Value Per Share	1.27	1.26	1.52	1.63	-4.14
Tangible Book Value	1,545	1,511	1,648	1,760	-3,067
Tangible Book Value Per Share	1.18	1.14	1.23	1.31	-4.86
Machinery	76.27	69.07	62	47.1	39.74
Construction In Progress	-	-	-	5.76	-
Leasehold Improvements	88	78.53	81.01	78.3	75.8

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error